세계의 뼈성장 자극기 시장 : 시장 인사이트, 경쟁 구도 시장 예측(2032년)

Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, and Ultrasonic Bone Growth Stimulators}, and Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), End-User (Hospitals, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of bone-related disorders, increase in sports injuries and accidents, and increase in product development activities by key market players across the globe.

The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032. The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

Bone Growth Stimulators Market Dynamics:

According to the latest data provided by the World Health Organization (WHO) (2023), approximately 528 million people globally were living with osteoarthritis and 18 million people were living with rheumatoid arthritis. The knee was the most commonly affected joint, with 365 million cases, followed by the hip and hand joints. In both conditions, the natural healing of bones is often impaired, necessitating interventions that promote bone regeneration and repair. Bone growth stimulators, which use electrical, ultrasound, or magnetic fields to stimulate bone healing, are becoming essential tools in managing these conditions thereby boosting the overall market of bone growth stimulators across the globe.

Moreover, the rise in road traffic accidents is another major factor leading to the rising demand for bone growth stimulators. According to the recent data provided by the World Health Organization (WHO) (2023), approximately 20 to 50 million people suffered non-fatal injuries, with many incurring a disability in road traffic injuries. Road traffic accidents (RTAs) are a major contributor to traumatic injuries, particularly fractures and severe bone damage, which can significantly boost the market for bone growth stimulators. These devices accelerate the healing process, especially in complex or high-risk fractures where traditional healing methods may be insufficient.

Additionally, as per the recent data provided by the World Health Organization (2024), globally, over 15 million people were living with spinal cord injury. Spinal cord injuries often result in severe fractures and vertebral damage, which can impair bone healing and spinal stability. Patients with spinal cord injuries frequently require surgeries, such as spinal fusions, to stabilize the spine and facilitate recovery. Bone growth stimulators, which use electrical, magnetic, or ultrasound stimulation, are increasingly used as an adjunct therapy to enhance bone regeneration and promote successful fusion in these cases.

Moreover, the increase in product launches and approval across the globe is further propelling the overall market of bone growth stimulators. For instance, in April 2024, Xstim, Inc., received FDA approval for Xstim(TM) Spine Fusion Stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.

However, invasive bone growth stimulators require surgical implantation of electrodes, which introduces risks associated with surgery, such as infection, bleeding, and complications related to anesthesia and the increased number of product recalls may hinder the future market of bone growth stimulators market growth.

Bone Growth Stimulators Market Segment Analysis:

Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, and Ultrasonic Bone Growth Stimulators}, and Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), End-User (Hospitals, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the bone growth stimulators market, the Capacitive Coupling (CC) devices category is expected to hold the largest share in the year 2024. Capacitive coupling devices are significantly boosting the overall market of bone growth stimulators due to their non-invasive nature and proven effectiveness in enhancing bone healing. These devices work by delivering a low-level electrical signal through capacitive plates placed on the skin, creating an electric field that stimulates bone cells to accelerate the healing process. Unlike invasive procedures, capacitive coupling devices offer a safer and more comfortable option for patients recovering from fractures, spinal fusions, or non-union bones. Their ability to be used in home settings and their portability increase patient compliance and accessibility, making them a favored option in the orthopedic and trauma care markets. Additionally, capacitive coupling devices are particularly beneficial for patients who cannot undergo surgery or for whom conventional treatments have failed. As awareness of these benefits grows, alongside advancements in capacitive coupling technology, the demand for bone growth stimulators has seen a marked increase, further expanding the market. Moreover, the cost-effectiveness and ease of use of capacitive coupling devices make them an attractive option for healthcare providers, contributing to their growing adoption in both hospital and outpatient settings.

Several innovative CC-based products illustrate the impact of this technology on the market. For instance, the Xstim(TM) Spine Fusion Stimulator by Xstim, Inc., is a non-invasive device designed to promote bone growth following spinal fusion surgery. It features an intuitive interface and a built-in capacitive coupling mechanism to deliver consistent, effective therapy. Another example is Theragen's ActaStim(R) System, which offers a sleek, wearable solution combining CC-based electrical stimulation with real-time data collection for enhanced compliance and personalized care. These devices are gaining traction not only in the United States but also in global markets, driven by the increasing incidence of spinal disorders, orthopedic trauma, and demand for alternatives to repeat surgeries. As clinical evidence continues to support their efficacy and manufacturers integrate user-friendly features and digital connectivity, capacitive coupling devices are playing a pivotal role in the growth of the bone growth stimulator market.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global bone growth stimulators market during the forecast period.

North America is expected to dominate the overall bone growth stimulators market:

Among all regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. Key drivers fueling this growth include the rising prevalence of bone-related disorders, an increase in sports-related injuries and accidents, supportive government initiatives, and the strong presence of key market players actively engaged in strategic developments. Collectively, these factors are anticipated to significantly boost the demand for bone growth stimulators across the region.

According to recent data from the Centers for Disease Control and Prevention (CDC, 2024), the age-adjusted prevalence of diagnosed arthritis among U.S. adults aged 18 and older was 18.9% in 2022. Women were more likely to be affected (21.5%) than men (16.1%). The prevalence of arthritis increases with age, rising from 3.6% among adults aged 18-34 to 53.9% in those aged 75 and older. As arthritis progresses, it often results in joint deterioration, bone erosion, and non-healing fracture conditions that require advanced interventions to stimulate bone regeneration. Bone growth stimulators, which utilize electrical or ultrasound stimulation, play a critical role in accelerating bone healing and alleviating pain. Their use in managing arthritis-related complications is therefore contributing to the expansion of the market in North America.

Furthermore, as per CDC data (2023), there were approximately 25.5 million emergency department visits in the U.S. due to unintentional injuries. The growing number of injuries increases the need for effective bone healing technologies. Bone growth stimulators offer improved recovery times and reduced complications, making them a valuable solution for a broad range of injury-related cases.

In addition, the presence of leading medical device manufacturers such as Arthrex Inc., Stryker Corporation, and Medtronic along with their strategic initiatives focused on product innovation and expansion further drives market growth in the region. These companies are actively developing advanced bone growth stimulators to address a variety of bone-related conditions, strengthening the market landscape and enhancing access to innovative solutions.

In summary, the combination of a high disease and injury burden, robust healthcare infrastructure, active government initiatives, and the strong presence of leading players positions North America as a dominant force in the global bone growth stimulators market during the forecast period.

Bone Growth Stimulators Market Key Players:

Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

Recent Developmental Activities in the Bone Growth Stimulators Market:

• In August 2022, Theragen, a biologics company, announced that it received the U.S. Patent for its ActaStim-S spine fusion bone growth stimulator system.
• In May 2022, Orthofix US LLC. received FDA approval for the AccelStim bone growth stimulator. The AccelStim bone growth stimulator delivers a high-frequency sound wave (ultrasound signal) to encourage bone growth and help heal broken bones (bone fractures).

Key takeaways from the bone growth stimulators market report study:

• Market size analysis for current bone growth stimulators size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the bone growth stimulators market.
• Various opportunities available for the other competitors in the bone growth stimulators market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current bone growth stimulators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bone growth stimulators market growth in the coming future?

Target audience who can benefit from this bone growth stimulators market report study:

• Bone growth stimulator product providers
• Research organizations and consulting companies
• Bone growth stimulators-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in bone growth stimulators
• Various end-users who want to know more about the bone growth stimulators market and the latest technological developments in the bone growth stimulators market.

Frequently Asked Questions for the Bone Growth Stimulators Market:

1. What are bone growth stimulators?

• A bone stimulator is a device that generates an electric current used to promote bone growth. It uses ultrasonic or pulsed electromagnetic waves. Bone stimulators are either external or surgically implanted into the area of the affected bone.

2. What is the market for bone growth stimulators?

• The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032.

3. What are the drivers for the bone growth stimulators market?

• The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

4. Who are the key players operating in the bone growth stimulators market?

• Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

5. Which region has the highest share in the bone growth stimulators market?

• Among all the regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. The key driving factors of the bone growth stimulators market are the increasing prevalence of bone-related disorders, an increase in sports-related injuries and accidents, increased government initiatives, and the presence of key players engaged in strategic activities in the region. Collectively, these factors are expected to boost the overall market of bone growth stimulators across the region.

Table of Contents

1. Bone Growth Stimulators Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Bone Growth Stimulators Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Bone Growth Stimulators Market Key Factors Analysis

• 5.1. Bone Growth Stimulators Market Drivers
  • 5.1.1. The rising incidence of bone-related disorders
  • 5.1.2. Increase in sports injuries and accidents
  • 5.1.3. Increase in product development activities by key market players across the globe.
• 5.2. Bone Growth Stimulators Market Restraints and Challenges
  • 5.2.1. Invasive bone growth stimulators require surgical implantation which introduces risks such as infection, bleeding, and complications
  • 5.2.2. The increased number of product recalls
• 5.3. Bone Growth Stimulators Market Opportunities
  • 5.3.1. Ongoing technological advancements such as enhanced electrical stimulation devices and ultrasound-based systems

6. Bone Growth Stimulators Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Bone Growth Stimulators Market Assessment

• 7.1. By Product
  • 7.1.1. Bone Growth Stimulation Devices
    • 7.1.1.1. Non-invasive Bone Growth Stimulators
    • 7.1.1.1.1. Combined Magnetic Field (CMF) Devices
    • 7.1.1.1.2. Capacitive Coupling (CC) Devices
    • 7.1.1.1.3. Pulsed Electromagnetic Field (PEMF) Devices
    • 7.1.1.1.4. Ultrasonic Bone Growth Stimulators
    • 7.1.1.2. Invasive Bone Growth Stimulators
  • 7.1.2. Bone Morphogenetic Proteins (BMP)
  • 7.1.3. Platelet-rich plasma (PRP)
• 7.2. By Application
  • 7.2.1. Spinal Fusion Surgeries
  • 7.2.2. Delayed Union & Nonunion Bone Fractures
  • 7.2.3. Oral & Maxillofacial Surgeries
  • 7.2.4. Others
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Homecare
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.3. India Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Bone Growth Stimulators Market Size in USD million (2022-2032)

8. Bone Growth Stimulators Market Company and Product Profiles

• 8.1. Zimmer Biomet
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Orthofix Medical Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. DJO, LLC
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Bioventus
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. BTT Health GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Stimulate Health
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Kinex Medical Company, LLC.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Fintek Bio-Electric Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Regen Lab SA
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Arthrex, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Altis Biologics (Pty) Ltd.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. TERUMO BCT, INC.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Medtronic
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. DePuy Synthes (Johnson & Johnson)
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. T-Biotechnology
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. D.r PRP USA LLC.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Ossatec Benelux BV
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. ITO Co., Ltd.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Theragen
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Xstim, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us